SEC 13F Intelligence

Boxer Capital Management, LLC / PTGX

Boxer Capital Management, LLC’s Protagonist Therapeutics Inc Position

Does Boxer Capital Management, LLC own Protagonist Therapeutics Inc (PTGX)? Yes — 170.0K shares worth $18M (+2.35% of its 13F portfolio) as of Q1 2026.

Position Value
$18M
Q1 2026
Shares
170.0K
% of Portfolio
+2.35%
Quarters Held
4
currently held

Position History PTGX

Reported value by quarter
Q2 ’25: $3MQ2 ’25Q3 ’25: $7MQ3 ’25Q4 ’25: $15MQ4 ’25Q1 ’26: $18MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026170.0K$18M+2.35%
Q4 2025170.0K$15M+3.25%
Q3 2025110.0K$7M+2.33%
Q2 202560.0K$3M+1.67%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boxer Capital Management, LLC’s full portfolio or all institutional holders of PTGX.